Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of the Value of the Cytogenetic and of the Monitoring of the Minimal Residual Disease

NCT00390715 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT00390715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00390715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of the Value of the Cytogenetic and of the Monitoring of the Minimal Residual Disease
Lead sponsor
PETHEMA Foundation
Phase
Observational
Overall status
Completed
Start date
January 31, 1999
Completion date
January 31, 2010
Enrollment
600 (estimated)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloblastic leukemia